MAR 09, 2021 8:00 AM PST

Ultrahigh-content imaging: a breath of fresh air for lung cancer research

Sponsored by: Miltenyi Biotec
Speaker
  • Global Product Manager for Ultrahigh-Content Imaging at Miltenyi Biotec
    Biography

      Telma Santos gained ten years of experience in fluorescence microscopy in academia and industry and combines expert knowledge in a wide range of microscopy techniques such as confocal microscopy, STED, and spinning disc microscopy for live-cell and 3D imaging. After studying axonal growth at the German Center for Neurodegenerative Diseases (DZNE) in Bonn, Germany, Telma joined Miltenyi Biotec in 2019 and is currently managing the market access of the newly developed MACSima™ Imaging Platform.


    Abstract

    Date:  March 09, 2021

    Time: 8:00am (PST),  11:00am (EST)

     

    Lung cancer is one of the three most common types of cancer. Representing 85% of all lung cancers, non-small cell lung cancer has the highest cancer mortality rate worldwide. Therefore, research into possible therapeutic or preventative approaches is understandably fast and furious.

    In this webinar, Dr. Telma Santos, Global Product Manager for Ultrahigh-Content Imaging at Miltenyi Biotec, will demonstrate how the MACSima™ Imaging Platform unlocks truly unprecedented insight into the spatial organization and complex functional interrelationship of cells in the tumor microenvironment.

    MICS (MACSima Imaging Cyclic Staining) technology allows imaging of hundreds of markers on a single sample and multiple samples in a single experiment. See how more than 150 antibodies were used to investigate two of the most common non-small-cell lung cancers (lung adenocarcinoma and squamous-cell carcinoma) with special focus on the infiltration of immune cells into the tumor tissue. In-depth analysis by the platform’s state-of-the-art Qi Tissue software also allowed the identification of the most common cell types relevant for immuno-oncology research. In addition, data for cell numbers, structure, and spatial organization were extracted and compared throughout the tissue.

    The possibility of analyzing hundreds of markers on a single sample not only facilitates the identification of basic structures, but it also enables the analysis of a plethora of proteins to advance biomarker research, drug target discovery, and deep phenotyping. Ultimately, all these approaches can help advance research towards the development of novel diagnostics and therapies.

    Make no mistake: This webinar redefines what it means to draw insight from imaging experiments, so register now!

     

     

     

    Webinars will be available for unlimited on-demand viewing after live event.


    Show Resources
    You May Also Like
    MAY 11, 2021 10:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    C.E. CREDITS
    MAY 11, 2021 10:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Date: May 11, 2021 Time: 10:00zm PDT Your samples are some of the most valuable assets in the laboratory. After spending countless hours on extraction and preparation, your conclusions could...
    NOV 18, 2020 8:00 AM PST
    C.E. CREDITS
    NOV 18, 2020 8:00 AM PST
    DATE: November 18, 2020 TIME: 08:00am PDT We develop and implement technologies to solve some of the major bottlenecks in biomedical research. In particular, we establish new imaging approac...
    OCT 29, 2020 6:00 AM PDT
    C.E. CREDITS
    OCT 29, 2020 6:00 AM PDT
    Date: October 29, 2020 Time: 6:00am (PDT), 9:00am (EDT), Chronic inflammation can occur as a result of a combination of genetic predispositions and environmental factors. Epigenetic modifica...
    APR 01, 2021 8:00 AM PDT
    C.E. CREDITS
    APR 01, 2021 8:00 AM PDT
    Date: April 01, 2021 Time: 8:00am (PST), 11:00am (EST) Generating therapeutic antibodies is far more challenging than obtaining antibodies that merely recognize their targets. Engineering po...
    NOV 16, 2020 8:00 AM PST
    C.E. CREDITS
    NOV 16, 2020 8:00 AM PST
    Date: November 16, 2020 Time: 8:00am (PST), 11:00am (EST) CRISPR screening has become the prime discovery tool in modern biomedical research and drug discovery. At the same time, most screen...
    FEB 24, 2021 10:00 AM PST
    C.E. CREDITS
    FEB 24, 2021 10:00 AM PST
    DATE: February 24, 2021 TIME: 10am PST Automated lab instruments such as liquid handlers and cell sorters are increasingly common in all types of laboratories, driving fast results for labor...
    Loading Comments...
    Show Resources
    Attendees
    • See more